fibrotic diseases

April 18, 2017April 19, 2017

Bristol-Myers, Nordic Partnering on Development of Biomarkers for Fibrotic Diseases

Bristol-Myers Squibb and Nordic Bioscience have agreed to work together to develop biomarkers for diagnosing and monitoring patients with fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF). IPF is a fatal, rare lung ... Read more

July 27, 2016July 27, 2016

AdAlta Goes Public to Speed New Therapies for Lung Fibrosis

Idiopathic Pulmonary Fibrosis, News

AdAlta, a drug company, is looking to raise $10 million with an initial public offering (IPO) on the Australian Securities Exchange. The sum will be used to support trials on AD-114, the company’s lead ... Read more

June 14, 2016June 14, 2016

Boehringer Ingelheim, Harvard Scientists Partner to Develop Novel Treatments for IPF, Other Fibrotic Diseases

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim and Harvard Stem Cell Institute’s (HSCI) Harvard Fibrosis Network recently announced a new research partnership to find novel treatments for fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF), chronic kidney ... Read more